One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Healthcare IT ➤ AI In Cardiology Market
AI In Cardiology Market
AI In Cardiology Market
Published date: March 2024 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Healthcare IT ➤ AI In Cardiology Market

Global AI in Cardiology Market- By Component (Hardware, Software, Services), By Applications (Stroke, Cardiac Arrhythmias, Ischemic heart disease/CAD, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

  • Published date: March 2024
  • Report ID: 116221
  • Number of Pages: 378
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • By Component Analysis
    • By Application Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunities
    • Latest Trends
    • Regional Analysis
    • Market Player Analysis
    • Recent developments
    • Report Scope

    Report Overview

    The Global AI In Cardiology Market was valued at the USD 1.5 Billion in 2023 and is projected to reach a substantial growth of the USD 40.5 Billion by 2033, with a CAGR of 39.4%.

    The term AI in cardiology refers to the applications of machine learning techniques and advanced automated algorithms in order to analyze and interpret medical data related to cardiovascular diseases. Artificial intelligence is applied across diverse aspects of cardiovascular cure such as diagnosis, risk assessment, medical imaging analysis, treatment planning, remote patient monitoring, predictive analytics and drug discovery.

    AI in Cardiology Market Size

    AI display magnificient application in the fied of cardiology and has a strong trust enhancing accuracy, efficiency, and personalized approach for cardiovascular conditions’ management, thereby resulting into ameliorated patient outcomes coupled with enhanced effective healthcare interventions. In addition, the technology steamlines, automates administrative work, and enhance clinical decision making through real time data analysis.

    The market for AI in cardiology is significantly driven by future advancements in AI technology, rising investments by healthcare sectors and collaborational efforts among market players, leading to a more sophisticated market growth. In addition, the heightening cases of cardiovascular diseases further up scale the demand for AI in cardiology solutions, leading to market growth.

    • According to World Health Organization, 86.4% of people suffer from heart attacks and strokes, with an average death cases of the USD 17.9 million annually by virtue of cardiovascular diseases.

    Key Takeaways

    • Market Size: AI In Cardiology Market was valued at the USD 1.5 Billion in 2023 and is projected to reach a substantial growth of the USD 40.5 Billion by 2033
    • Component Analysis: Software segment to dominate the AI in cardiology market 61.3% share in the year 2023.
    • Application Analysis: coronary artery disease significantly occupied major portion of the market securing a revenue share of 54.6% in the year 2023.
    • Regional Analysis: North America resulted the region to secure an absolutely impressive market share of 60.1% in the year 2023.
    • Based on components, the market is segmented into hardware, software and services, with software segment being the higest involved in the market growth.
    • Coronary artery disease leads the market for AI in cardiology depending upon application analysis.
    • One of the primary driver fostering the growth of the market is escalating prevalence of cardiovascular illnesses.
    • The market for AI in cardiovascular illnesses is the rising concern related to data breaches and security of patient’s data.
    • North America withheld a remarkable market share in the year 2023.
    • Asia-Pacific is anticipated to witness the fastest growing market owing to improved healthcare infrastructure coupled with rising incidences of cardiovascular conditions.
    • Major market players have a keen focus to strategies their products leading to the development of innovations in AI based solutions for treating heart related illnesses.

    By Component Analysis

    Software segment to dominate the AI in cardiology market

    The market for AI in cardiology is broadly categorized into three segment, i.e., hardware, software and services components. Amongst these, software component is at the forefront of the global AI in cardiology market capturing a commendable market share of 61.3% in the year 2023. The segment further promises to showcase huge growth with the fastest CAGR of 36.4% during the foreseen period. The dominance of software component is as a result of soaring demand for AI based diagnostic solutions providing highly precise diagnosis for cardiac patients.

    The success of the segment can be further attributed to enhanced productivitiy, physicians’ decision making aided by data analysis, thus providing better heart analysis. Many major companies are significantly involved to strategies their products through several modes including partnerhsips and fundings, thereby building their strong presence in the marketplace.

    • A Series C funcing of the USD 192 million was raised by Clearly with the aim to develop AI based software to diagnose atherosclerosis.

    By Application Analysis

    The market growth is elevated by rising demand of AI

    With respect to applications, the market is fractionated into Stroke, Cardiac Arrhythmias, Ischemic heart disease/CAD and other applications. Surprisingly, the others category closely followed by coronary artery disease significantly occupied major portion of the market securing a revenue share of 54.6% in the year 2023. Escalating pervasiveness of the respected diseases is the primary factor driving the growth of the market to a remarkable extent.

    Higher the cases high is the rate of adopting AI for the purpose of diagnosing and thereby treating coronary artery diseases. Thus, the incorporation of AI in making crucial decisions by automation and standardization of the outcome to improve precision in diagnosis, further propels the segment to an outstanding position.

    • Approximately, USD 244.1 million people were suffering from coronary artery disease in 2020, according to American Heart Association.

    AI in Cardiology Market Share

    Key Market Segments

    By Component

    • Hardwarwe
    • Software
    • Services

    By Application

    • Stroke
    • Cardiac Arrhythmias
    • Ischemic heart disease/CAD
    • Other applications

    Drivers

    Rising pervasiveness of Cardiovascular illnesses

    The market for AI in cardiology is significantly driven by rising prevalence of cardiovascular dieases such as stroke, heart disease and other heart related conditions. Being critical diseases resulting in huge cases of morbidity and mortality across the globe, necessitates high technologies such as AI to accelerate early detection, diagnosis and personalized treatment. For instance, a most common type of heart disease is Coronary heart disease (CHD) leading to an approx 375,476 mortality rates worldwide.

    In addition, every year United States encounters approximately 6,95,000 number of deaths by virtue of heart disease, according to Cardiovascular Disease Data and Statistics. Thus, the rising cases of cardiovascular illnesses demands AI based treatment for early diagnosis, detection and treatment of the diseases, driving the growth of the market.

    Restraints

    Data breaching and security concerns

    AI in cardiology market finds barrier towards market excellence due to crucial roadblocks such as risk related to data privacy and security perturbs. As AI in cardiology deals with loads of considerate data such as medical records, genetic information and images, there rises concerns of data leakage and breaching. If this is the case, the trust among healthcare providers and patients is disrupted, limiting the adoption of artificial intelligence based solutions in the healthcare settings.

    Thus, compliance with data protection regulations is important to ensure data privacy and security to procure trust among patients and healthcare providers, which further leads to elevated cost of the procedures.

    Opportunities

    Collaborational efforts results into smooth growth of the market

    The AI in cardiology market gains tremendous growth opportunities with the escalating collaborational efforts and partnerships among technology companies, healthcare sectors and research institutions. These efforts cumulatively results into upheavals in AI applications for cardiology. Aided by partnerships, the market receives a forward push resulting into faster product development and address determined healthcare challenges.

    To exemplify the aforementioned fact, an eminent center for cardiology research, “Cardiovascular Research Center Aalst” made a partnership with “PMcardio”, a company in AI-powered cardiovascular diagnostics, with the aim to carry forward joint research and development. This led to an innovative combination of PMcardio’s cutting edge technology with Aalst Center’s clinical expertise, offering attractive avenues for market growth in the foreseeable days.

    Impact of Macroeconomic Factors

    The soaring inflation rates have considerably affected the AI in cardiology market in recent years. Prices of medical products and services rises with inflation. Cardiac patients are much more vulnerable to inflation, seeing that AI based treatments are quite expensive and at times inaccessible to begin with. According to International Monetary Fund, rate of inflation is expected to fall down to 4.1% by the year 2024. This forecast is promising for cardiac patients since it suggests a decrease in healthcare costs.

    Latest Trends

    AI in cardiology market excels forward with the ongoing innovations in AI based technologies. Some of these include:

    Innovation in AI based Diagnostic ECG: Advancements are made in CT Scar Imaging and Wall thickness analysis which is based on vMap AI based solutions. This led to map arrhythmias using a 12 lead ECG. Vektor medical played a pivotal role in improving the AI based techniques to bring out promising outcomes.

    Machine learning and Deep Learning: These advanced techniques are at the forefront of AI advancements in cardiology. These algorithms assists to analyze large datasets, identify patterns, allowing accurate risk assessment and personalized treatment plans. Thus, automation and enhancement of analysis of medical images including angiograms, cardiac MRIs and echodardiograms can be easily done by AI algorithms, thereby enabling quick witted and accurate diagnosis of cardiac conditions.

    Regional Analysis

    North America leads the global AI in Cardiology market

    While North America dominated the global AI in cardiology market, Asia Pacific is anticipated to witness fastest growing market during the forecast period owing to the factors such as  growing elderly population, advancements in healthcare insrastructure and ameliorated economy of the region. The domination of North America resulted the region to secure an absolutely impressive market share of 60.1% in the year 2023.

    The regions’ accomplishment is due to the fact of well established healthcare infrastructure, increased regulatory approvals of AI products coupled with expeditious adoption of technologically advanced products. In addition, the regions’ high prevelance of cardiovascular illnesses further bolsters the position of region, propelling the market growth.

    • LVivo IQS software solution, a product of Dia Imaging Analysis received approval from United States Food and Drug Administration, to provide high quality echocardiography images to the healthcare professionals.
    • On an average, 7.3% of the population with age 20 or above have coronary artery disease, afflicting 8.3% of men and 6.1% of women in North America.

    AI in Cardiology Market Region

    Key Regions and Countries

    North America

    • US
    • Canada

    Europe

    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Russia
    • Netherland
    • Rest of Europe

    Asia Pacific

    • China
    • Japan
    • South Korea
    • India
    • New Zealand
    • Singapore
    • Thailand
    • Vietnam
    • Rest of APAC

    Latin America

    • Brazil
    • Mexico
    • Rest of Latin America

    Middle East & Africa

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA

    Market Player Analysis

    Being fragmented with many large and medium sized players, the global AI in Cardiology market is experiencing greater growth opportunities for its excellence. The major market players are into strategizing products by acquisitions and mergers leading to the development and introduction of highly advanced AI technology.

    Top Key Players

    • Cleerly, Inc
    • DiA Imaging analysis
    • Arterys Inc
    • CardiAI
    • IDOVEN
    • RSIP Vision
    • Cardiologs
    • UltraSight
    • Ultromics Ltd
    • CathWorks
    • Boston Scientific Corporation
    • Canon, Inc

    Recent developments

    • In March 2023: Aidoc introduced its premium, cutting edge cardiovascular AI solutions package at American College of Cardiology annual conference in New Orleans. This cardiovascular solution allows combining the data aided by AI to produce clinical insights for precise diagnosis and accelerate communication to assists patients being lost to follow up, thereby resulting into an elevation of downstream treatments.
    • In February 2023: PrecisionCHD was announced by Cardio Diagnosis Holdings. Being a second clinical test to deploy AI in it,  is an integrated genetic-epigenetic bloodtest for early prognosis of coronary heart diseases.

    Report Scope

    Report Features Description
    Market Value (2023) USD 1.5 Billion
    Forecast Revenue (2033) USD 40.5 Billion
    CAGR (2024-2033) 39.4%
    Base Year for Estimation 2023
    Historic Period 2018-2022
    Forecast Period 2024-2033
    Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments
    Segments Covered By Component (Hardware, Software, Services), By Applications (Stroke, Cardiac Arrhythmias, Ischemic heart disease/CAD, others)
    Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA.
    Competitive Landscape Cleerly, Inc, DiA Imaging analysis, Arterys Inc, CardiAI, IDOVEN, RSIP Vision, Cardiologs, UltraSight, Ultromics Ltd, CathWorks, Boston Scientific Corporation, Canon, Inc.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

    Frequently Asked Questions (FAQ)

    What is AI in cardiology?

    AI (Artificial Intelligence) in cardiology refers to the application of advanced computational techniques to analyze medical data related to heart health. It involves the use of algorithms and machine learning models to assist in the diagnosis, prediction, and treatment of cardiovascular diseases.

    How big is the AI In Cardiology Market?

    The global AI In Cardiology Market size was estimated at USD 1.5 Billion in 2023 and is expected to reach USD 40.5 Billion in 2033.

    What is the AI In Cardiology Market growth?

    The global AI In Cardiology Market is expected to grow at a compound annual growth rate of 39.4%. From 2024 To 2033

    Who are the key companies/players in the AI In Cardiology Market?

    Some of the key players in the AI In Cardiology Markets are Cleerly, Inc, DiA Imaging analysis, Arterys Inc, CardiAI, IDOVEN, RSIP Vision, Cardiologs, UltraSight, Ultromics Ltd, CathWorks, Boston Scientific Corporation, Canon, Inc.

    How is AI used in cardiology?

    AI is used in various aspects of cardiology, including image analysis (such as echocardiograms and MRI scans), risk prediction for heart diseases, personalized treatment planning, and remote patient monitoring. It helps in interpreting complex cardiac data more accurately and efficiently than traditional methods.

    What are the benefits of AI in cardiology?

    The benefits include improved accuracy in diagnosing heart conditions, early detection of abnormalities, personalized treatment plans based on patient-specific data, enhanced workflow efficiency for healthcare providers, and better patient outcomes through timely interventions and monitoring.

    What are the current trends in the AI in cardiology market?

    Current trends include the development of AI-powered medical devices and software for cardiac imaging and analysis, the integration of AI into electronic health records (EHR) systems, collaborations between technology companies and healthcare providers to deploy AI solutions, and the emergence of AI-driven predictive analytics for cardiovascular risk assessment.

    AI In Cardiology Market
    AI In Cardiology Market
    Published date: March 2024
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Cleerly, Inc
    • DiA Imaging analysis
    • Arterys Inc
    • CardiAI
    • IDOVEN
    • RSIP Vision
    • Cardiologs
    • UltraSight
    • Ultromics Ltd
    • CathWorks
    • Boston Scientific Corporation Company Profile
    • Canon, Inc
  • settingsSettings

Related Reports

  • AI in Medical Imaging Market
  • Smart Healthcare Market
  • Virtual Health Service Market
  • Healthcare BPO Market
  • Artificial Intelligence in Drug Discovery Market
  • Mental Health App Market
  • Healthcare Cybersecurity Market
  • Healthcare CRM Market
  • Patient Registry Software Market
  • Healthcare Claims Management Market

Our Clients

  • Our Clients
Inquiry Before Buying

AI In Cardiology Market
  • 116221
  • March 2024
    • ★★★★★
      ★★★★★
    • (74)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.